Association of PTPRT mutations with immune checkpoint inhibitors response and outcome in melanoma and non‐small cell lung cancer

PURPOSE: Protein tyrosine phosphatase receptor type T (PTPRT), which is a well‐known phosphatase and mutates frequently in melanoma and non‐small cell lung cancer (NSCLC). Our research aims to elucidate its mutation association with immune checkpoint inhibitors (ICI) efficacy. METHODS: We integrated...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Wenjing, Shi, Fuyan, Kong, Yujia, Li, Yuting, Sheng, Chao, Wang, Suzhen, Wang, Qinghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817076/
https://www.ncbi.nlm.nih.gov/pubmed/34862763
http://dx.doi.org/10.1002/cam4.4472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817076/
https://www.ncbi.nlm.nih.gov/pubmed/34862763
http://dx.doi.org/10.1002/cam4.4472

Ejemplares similares